Why is Folate Biosynthesis a Target for Antibiotics?
Humans acquire folate through their diet, whereas many bacteria must synthesize it de novo. This fundamental difference makes the folate biosynthesis pathway an attractive target for antibiotic development. Drugs such as sulfonamides and trimethoprim inhibit enzymes in this pathway, effectively starving bacteria of the folate they need to grow and reproduce, thereby limiting the infection.
